June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Should patients with sarcoidosis be screened for asymptomatic ocular inflammation?
Author Affiliations & Notes
  • Sarah Sunshine
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Dmitry Pyatetsky
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Andrea D Birnbaum
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Debra A Goldstein
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Sarah Sunshine, None; Dmitry Pyatetsky, None; Andrea Birnbaum, None; Debra Goldstein, Abbvie (C), Clearside (C), Psivida (C), Santen (C), Xoma (C)
  • Footnotes
    Support  Research to Prevent Blindness, Debra Goldstein
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2172. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sarah Sunshine, Dmitry Pyatetsky, Andrea D Birnbaum, Debra A Goldstein; Should patients with sarcoidosis be screened for asymptomatic ocular inflammation?. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2172.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : (1) Determine the utility of screening examinations in asymptomatic patients with systemic sarcoidosis (2) Determine the proportion of sarcoidosis patients with conjunctival lesions that could serve as a potential biopsy site.

Methods : IRB approval was obtained for this prospective study. Patients with biopsy proven systemic sarcoidosis and no history of uveitis who were referred for ocular screening underwent review of systems, medical history, complete ocular examination. Patients with symptoms consistent with uveitis were excluded. Signs of ocular inflammation including conjunctival granulomas, anterior chamber or vitreous cell, retinal vasculitis, choroiditis, macular edema were recorded.

Results : 42 patients were included. 60% were female; mean age was 52.5 years (range 32-69); 24% self-reported as African American, 26% Caucasian, 4.8% Asian; 45% were of unknown race. 40 patients (95%) had no signs of ocular inflammation. Two patients had mild ocular inflammation requiring no additional treatment. One had rare anterior chamber cell and the other a solitary vitreous snowball. 43% were on systemic immunomodulatory therapy (IMT). 54% had conjunctival nodules in the inferior fornix, 33% of patients on IMT had conjunctival nodules and 70.8% of patients not on IMT had conjunctival nodules.

Conclusions : No patient with biopsy proven systemic sarcoidosis in this series had asymptomatic intraocular inflammation requiring therapy. Patients with systemic sarcoidosis should be advised of symptoms of ocular inflammation but, based on this small series, there is no evidence to suggest that they need routine screening for uveitis. Previous data from our group has suggested a diagnostic yield of 63% when conjunctival lesions are biopsied and multi-planar sectioning performed ([i]). More than half the patients in this series had conjunctival nodules, and these were more likely to be seen in patients not on anti-inflammatory therapy. Patients with suspected systemic sarcoidosis and no easily accessible site for biopsy may be referred for ophthalmic examination to look for conjunctival nodules that can be biopsied for pathologic diagnosis.

[i] KM Bui, JM Garcia-Gonzalez, SS Patel, AY Lin, DP Edward,DA Goldstein. Directed Conjunctival Biopsy and Impact of Histologic Sectioning Methodology on the Diagnosis of Ocular Sarcoidosis. J Ophthalmic Inflamm Infect. 2014 Mar 18;4(1):8.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×